Dr Briffa's Blog – A Good Look at Good Health
  • Homehomepage
  • Booksby Dr Briffa
    • Printed Books
      • Escape the Diet Trap
      • Waist Disposal
      • The True You Diet
      • Natural Health for Kids
    • Audio Books
      • Overcoming Fatigue and Tiredness and Boosting Energy
      • Overcoming Joint Pain and Arthritis
      • Banishing IBS
    • E-Books
      • 6 Essentials to Physical Health and Wellbeing
      • 6 Essentials to Emotional Health and Happiness
  • Bloglatest posts
    • Blog Archives
  • Fit for Businesscorporate programmes
    • Programmes & Lectures
    • Benefits
    • Testimonials & Feedback
    • Client List
    • Contact
  • Aboutabout Dr Briffa
  • Newsletterplus free e-book
  • Contactget in touch

Weight loss drugs revealed to have only slim benefits

HomeHome → Food and Medical Politics → Weight loss drugs revealed to have only slim benefits
Nov, Mon 19th, 2007 Posted in : Food and Medical Politics, Weight Loss By : Dr John Briffa 4 Comments

Earlier this month I blogged about some research which suggests that being overweight is not the dire threat to our health and longevity it is so often assumed to be. One reason why the risk of being overweight may be somewhat overstated has to do with the fact there’s a lot of money in persuading people that they should be lighter than they are. In particular, the food and pharmaceutical industries stand to do well out through the sale of weight loss drugs and ‘diet’, ‘lite’ and ‘low-fat’ foods that make an implicit weight loss promise.

I take a generally dim view of foods that have been manipulated in a way that supposedly gives them advantages to would-be slimmers. Such foods are generally sold on the basis that fat is inherently fattening (which studies suggest it is not) or that artificial sweeteners induce weight loss compared to sugar (also unproven).

The drugs used to treat excess weight come in a variety of forms. The main players are:

Orlistat (trade names Xenical and Alli) which blocks the digestion of fat

Sibrutamine
(Reductil, Meridia) which is an appetite suppressant

Rimonabant (Acomplia) which limits the absorption of fat from the digestive tract

The effectiveness of these drugs with regard to weight loss was assessed this week in a study published on-line in the British Medical Journal (BMJ) [1]. The review looked at the available evidence from studies in which these drugs had been compared with placebo.

The results revealed that the average weight loss attributed to the orlistat, sibutramine and rimonabant were 2.9 kg (4.6 lb), 4.2 kg (9 lb) and 4.7 kg (10.5 lb) respectively.

The study also found that 30-40 per cent of individuals defaulted from their treatment. One reason for this, of course, is that individuals may have got the impression that what they were taking was not having the desired effect. Another reason relates to the fact that these medications are not without side-effects. For instance, rimonabant is associated with an increased risk of anxiety and depression. While orlistat is associated with, amongst other things, ‘oily leakage’ from the anus.

What is more, the weight loss effects of these drugs was generally regarded by the authors of this review as modest. The loss of 5 kg equates to less than 5 per cent of the total body weight. The authors note that the National Institute for Health and Clinical Excellence (NICE) here in the UK recommend that if a drug does not lead to a loss of at least 5 per cent of body weight within 3 months then it should be stopped.

Another issue concerns the fact that while these drugs may bring weight loss and even other apparent benefits (e.g. orlistat is associated with a reduced risk of diabetes), we don’t actually know what the effects these drugs have on broader measures of health and risk of mortality.

Taken as a whole, the evidence we have available suggests that weight loss drugs have limited benefits for individuals. Add to that the increasing evidence which suggests that carrying ‘excess’ weight is not nearly as hazardous as we have been led to believe, and we might question what place such weight loss drugs have in medical practice.

References:

1. Rucker D, et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007 Nov 15 [Epub ahead of print]

Related article:

Doctors come clean about the effectiveness of weight loss drugs

← Walking found to lower cardiovascular disease risk in diabetics
Vitamin D may hold the key for those who ‘hurt all over’ →

4 Responses to Weight loss drugs revealed to have only slim benefits

  1. Lady Light
    21 November 2007

    A very sensible perspective on this issue. I am increasingly of the opinion that there is no ‘quick fix’ to weight iproblems. Very interesting blog.

  2. Hilda
    23 November 2007

    Another worrying thing is the number of adverts advertising stomach stapling or the like in this country. I cannot understand how one can be well nourished with a stomach the size of a thumb. In my practice I see so mnay people who say tey cant cook and live on processed foods. THis is the main problem

  3. Bo Piltson
    23 November 2007

    Sibce dietary fat is not a primary cause of body fat, a drug that is said to block fat absorbtion seems meaningless to me. So why use Orlistat/Xenical in the first place, regardless of its effectiveness or lack of it? As I understand it, its purpose is only to stop people from eating fat. Why should they?

  4. May
    4 June 2009

    You’d better get rid of the idea that you’ll never get weight loss except through pills!Following a balanced diet depending on vegetables in the first rank is absolutely much more effective!

Click here to cancel reply.

Leave a Reply

Post Comment

Recent Posts

  • Power to the people May 11, 2012
  • Another reason to avoid sunscreens May 11, 2012
  • Study suggests that insulin may drive weight gain after stopping smoking May 11, 2012
  • Getting more sleep could make it easier to control our weight May 2, 2012
  • Prominent cardiologist reveals some of the the flaws in conventional cholesterol wisdom April 30, 2012
  • The dark side of sunscreens April 30, 2012

Categories

  • Brain and Behaviour (156)
  • Children's Health (87)
  • Cholesterol and Statins (77)
  • Diabetes/Metabolic Syndrome (111)
  • Exercise and Activity (88)
  • Food and Medical Politics (288)
  • Healthy Eating (544)
  • Herbal Medicine (42)
  • Low-Carbohydrate (163)
  • Men's Health (37)
  • Nutrients and Supplements (211)
  • Pregnancy and Fertility (24)
  • Sleep (43)
  • Specific conditions (197)
  • Stress (5)
  • Sunlight (99)
  • Unhealthy Eating! (271)
  • Weight Loss (243)
  • Women's Health (144)

Dr Briffa’s Newsletter

Recent Posts

  • Power to the people Power to the people May 11, 2012
  • Another reason to avoid sunscreens Another reason to avoid sunscreens May 11, 2012
  • Study suggests that insulin may drive weight gain after stopping smoking Study suggests that insulin may drive weight gain after stopping smoking May 11, 2012

Navigate

  • Home
  • About Dr Briffa
  • Blog
  • Printed Books
  • Audio Books
  • E-Books
  • Newsletter
  • Fit for Business
  • Contact

Dr John Briffa
+44 (0)20 8341 3422
john@drbriffa.com

© 2002-2012 Dr John Briffa
Website Designed by New Earth Vision

Disclaimer:

Information and advice contained in this website should not be used for the purposes of diagnosis or as a substitute for medical advice. Always consult your doctor or healthcare professional before beginning any new treatment or regime. Dr John Briffa assumes no responsibility or liability for any consequence resulting directly or indirectly for any action or inaction you take based on the information contained in this website.